LoadingVZ
SCHULMAN DANIEL H reported Grant or award in VERIZON COMMUNICATIONS INC: 201.115 units of Phantom Stock (unitized) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
VZ
Malady Kyle reported Grant or award in VERIZON COMMUNICATIONS INC: 131.364 units of Phantom Stock (unitized) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
FEAM
Weibel Paul Wesley III reported Purchase in 5E Advanced Materials, Inc.: 7175.8193 units of Common Stock, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
URGN
Degnan Chris reported Exercise or conversion in UroGen Pharma Ltd.: 4483 units of Ordinary Shares, dated 2026-10-08. The full Form 4 contains 3 transaction entries.
QTEX
Ben-Noon Dagi Shahar reported Purchase in QTREX Quantum Ltd.: 18181 units of Ordinary Shares, dated 2026-10-09. The full Form 4 contains 1 transaction entry.
WEC
STANEK MARY ELLEN reported Grant or award in WEC ENERGY GROUP, INC.: 351.3278 units of Phantom Stock Units (derivative), dated 2026-10-07. The full Form 4 contains 1 transaction entry.
WEC
Lane Thomas K reported Grant or award in WEC ENERGY GROUP, INC.: 302.8688 units of Phantom Stock Units (derivative), dated 2026-10-07. The full Form 4 contains 1 transaction entry.
WEC
Cunningham Danny L reported Grant or award in WEC ENERGY GROUP, INC.: 363.4425 units of Phantom Stock Units (derivative), dated 2026-10-07. The full Form 4 contains 1 transaction entry.
GRX
Saba Capital Management, L.P. reported Purchase in Gabelli Healthcare & WellnessRx Trust: 2955 units of Common Stock, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
PDX
Saba Capital Management, L.P. reported Sale in PIMCO Dynamic Income Strategy Fund: 3609 units of Common Stock, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
ECAT
Saba Capital Management, L.P. reported Sale in BlackRock ESG Capital Allocation Term Trust: 25204 units of Common Stock, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
GF
Saba Capital Management, L.P. reported Purchase in NEW GERMANY FUND INC: 1223 units of Common Stock, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
ECF
Saba Capital Management, L.P. reported Purchase in ELLSWORTH GROWTH & INCOME FUND LTD: 17548 units of Common Stock, dated 2026-10-07. The full Form 4 contains 1 transaction entry.
UXIN
Dai Kun reported Purchase in Uxin Ltd: 11836 units of American depositary shares, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
AGMB
Epstein David R reported Purchase in AgomAb Therapeutics NV: 5000 units of Common shares, dated 2026-10-08. The full Form 4 contains 1 transaction entry.
CHKP
SHWED GIL reported Gift in CHECK POINT SOFTWARE TECHNOLOGIES LTD: 4000 units of Ordinary Shares, NIS 0.01 Per Share, dated 2026-08-05. The full Form 4 contains 2 transaction entries.
TRXB
Ross Michael Jay reported Grant or award in TRex Bio, Inc.: 17500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
RTSN
Olds Donald reported Grant or award in Retension Pharmaceuticals, Inc.: 5636 units of Stock Option (right to buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
TRXB
MARCUS JOEL S reported Grant or award in TRex Bio, Inc.: 17500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
Rynders Perry M. reported 500 shares of Common Stock in Lodging Fund REIT III, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 8, 2026. These were stock awards, not open-market purchases.
Leighton Jeffrey T. reported 500 shares of Common Stock in Lodging Fund REIT III, Inc. as grants or awards dated 2026-09-30. The Form 4 was disclosed on Oct 8, 2026. These were stock awards, not open-market purchases.
TXTM
Jamaloodeen Ahmed reported Grant or award in ProText Mobility, Inc.: 66667 units of Series D Preferred Stock, dated 2022-06-03. The full Form 4 contains 9 transaction entries.
TRXB
Hirth Peter reported Grant or award in TRex Bio, Inc.: 17500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
TRXB
Gilmore Julie Ann reported Grant or award in TRex Bio, Inc.: 17500 units of Stock Option (Right to Buy) (derivative), dated 2026-10-08. The full Form 4 contains 1 transaction entry.
